Merotrax 500 mg/vial (IV Injection or Infusion)
500 mg vial: ৳ 700.00
Medicine Details
Category | Details |
---|---|
Generic | Meropenem trihydrate |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Product Title and Categories
- Merotrax - Carbapenem Antibiotic
- Medicine
- Antibiotics
- Therapeutic Class: Other beta-lactam Antibiotics
Indications
- Used for Pneumonia and Nosocomial Pneumonia
- Treats Urinary Tract Infections
- Effective for Intra-abdominal Infections
- Used in Gynaecological Infections
- Treats Skin and Skin Structure Infections
- Effective Against Meningitis
- Use for Septicaemia
- Treatment for Pulmonary infections in cystic fibrosis
- Empiric treatment for presumed infections in patients with febrile neutropenia
Pharmacology
- Meropenem is a carbapenem antibiotic for parenteral use
- Exerts bactericidal action by interfering with bacterial cell wall synthesis
- Shows potent bactericidal activity against a broad spectrum of bacteria
Dosage
- Recommended daily dosage for Adults and Children
- Different dosages for various types of infections
- Dosage adjustment for patients with renal impairment
- No dosage adjustment for patients with hepatic impairment
- Special dosage considerations for children, cystic fibrosis, and meningitis
Administration
- Administered by intravenous Infusion over approximately 15-30 minutes or as intravenous bolus over approximately 3-5 minutes
Interaction
- Probenecid competes with Merotrax for active tubular secretion
- Inhibits the renal excretion, increasing the elimination half-life and plasma concentration of meropenem
- Merotrax may reduce serum valproic acid levels
Contraindications
- Contraindicated in patients with demonstrated hypersensitivity to the product
Side Effects
- Possible side effects such as inflammation, thrombophlebitis, pain at the site of injection, skin reactions like rash, pruritus, urticaria, abdominal pain, nausea, vomiting, diarrhea, headache
Pregnancy & Lactation
- Pregnancy Category B - Caution advised during pregnancy
- Caution recommended when administered to nursing women due to potential excretion in human milk
Precautions & Warnings
- Discontinue if allergic reaction occurs
- Careful monitoring of transaminase and bilirubin levels in patients with hepatic disease
Use in Special Populations
- Dosage reduction in patients with renal impairment
- No dosage adjustments necessary in patients with hepatic impairment or elderly patients
- Efficacy and tolerability in infants under 3 months not established
Overdose Effects
- Symptomatic treatment in case of accidental overdose, particularly in patients with renal impairment
- Rapid renal elimination in normal individuals, hemodialysis for subjects with renal impairment
Reconstitution
- Instructions for intravenous bolus and intravenous infusion administration
- Compatibility with various infusion fluids
- Freshly reconstituted solution is recommended for potency
Storage Conditions
- Vial should be stored in a cool, dry place (below 30°C), away from light & moisture
- Keep out of reach of children
Related Brands
- Aronem 500 mg/vial (IV Injection or Infusion) - aci-limited
- Aronem 1 gm/vial (IV Injection or Infusion) - aci-limited
- Aropen 500 mg/vial (IV Injection or Infusion) - aristopharma-ltd
- Aropen 1 gm/vial (IV Injection or Infusion) - aristopharma-ltd
- Carbanem 500 mg/vial (IV Injection or Infusion) - synovia-pharma-plc